Hematologic Malignancies
Experts Present Findings at Annual Conference
Hematologic Malignancies staff will present the following research at the upcoming
American
Society of Hematology Annual Meeting in Atlanta December 8-11, 2007.
- University of Maryland Presentations
- University of Maryland Collaborations
- University of Maryland Session Chairs
University of Maryland Presentations
Oral Presentations
Saturday, December 8, 2007
| Time: |
7:30 AM and 4:00 PM |
| Room: |
C306-C308 |
| Presenters: |
Education Session: John R. Hess, M.D., Blood and
Coagulation Support in Trauma |
top
Sunday, December 9, 2007
| Time: |
5:30 PM |
| Room: |
Thomas B. Murphy Ballroom I |
| Presenters: |
Jinshui Fan, Annahita Sallmyr, Kyu-Te Kim, Kamal Datta, Paul Shapiro,
Donald Small, Feyruz V. Rassool. Internal tandem duplication
of FLT3 induces increased ROS production, DNA damage and misrepair:
Implications for genomic instability and disease resistance in myeloid
malignancies. |
top
Monday, December 10, 2007
| Time: |
11:15 AM |
| Rooms: |
A411-A412 |
| Presenters: |
Maria R. Baer, Stephen L. George, Ben L. Sanford,
Sandra M. Bothun, Krzysztof Mrozek, Kieran L. O’Loughlin, Jonathan
E. Kolitz, Joseph O. Moore, Richard M. Stone, Bayard L. Powell, Michael
A. Caligiuri, Clara D. Bloomfield, Richard A. Larson. Cytarabine, daunorubicin
and etoposide (ADE) chemotherapy in acute myeloid leukemia patients
> 60 years (CALGB 9720). |
top
Tuesday, December 11, 2007
| Time: |
7:30 AM |
| Rooms: |
B308-B309 |
| Presenters: |
Aaron P. Rapoport, Stephan A. Grupp, Edward A. Stadtmauer,
Robert H. Vonderheide, Bruce L. Levine, Hongbin Fang, Kelly Yager, Anne
Chew, Elizabeth Veloso, Carl H. June. Rapid T cell recovery and possible
auto-GVHD following adoptive transfer of ex-vivo costimulated autologousT
cells at day +2 post-transplant. |
top
Poster Presentations
Saturday, December 8, 2007
| Poster 170-I |
| Room: |
Hall B4 |
| Presenters: |
Annahita Sallmyr, Feyruz V. Rassool. Up-regulated
WRN and DNA ligase III? are involved in alternative NHEJ repair pathway
of DNA double strand breaks in chronic myeloid leukemia. |
| |
| Poster 322-I |
| Presenters: |
Ashraf Badros, S. Philip, R. Niesvizky, O Goloubeva,
C Harris, J Zweibel, J Wright, A Burger, S Grant, MR Baer, MJ Egorin.
Phase I trial of suberoylanilide hydroxamic acid (SAHA) + bortezomib
in relapsed multiple myeloma patients. |
top
Sunday, December 9, 2007
| Poster 253-II |
| Room: |
Hall B4 |
| Presenters: |
Attaphol Pawarode, Paul K Wallace, Laurie A Ford, Maurice Barcos,
Maria R. Baer. Long-term outcome of cyclosporin A therapy
for large granular lymphocyte leukemia. |
| |
| Poster 570-II |
| Presenters: |
Kieran L. O’Loughlin, Hans Minderman, Laurie A. Ford, Maria
R. Baer. Amonafide L-malate bypasses multidrug resistance ptoteins
in secondary acute myeloid leukemia. |
top
Monday, December 10, 2007
| Poster 738-III |
| Room: |
Hall B4 |
| Presenters: |
Ashraf Badros, T Evangelos, O Goloubeva, T Meiller,
E Kastritis, E Verrou, K Zervas, E Katodritou, E Streeten, MR Baer,
MA Dimopoulos. Long-term follow-up of multiple myeloma patients with
osteonecrosis of the jaw. |
top
University of Maryland Collaborations
Oral Presentations
Monday, December 10, 2007
| Time: |
11:15 AM |
| Room: |
Sidney J. Marcus Auditorium |
| Presenters: |
Peter Paschka, Guido Marcucci, Amy S Ruppert, Krzysztof Mrózek,
Susan P Whitman, Kati Maharry, Christian Langer C, Claudia D Baldus, Bayard
L Powell, Maria R. Baer, Andrew J Carroll, Michael A
Caligiuri, Jonathan E Kolitz, Richard A Larson RA, Clara D Bloomfield.
Wilms tumor 1 (WT1) gene mutations predict poor outcome in adults with
cytogenetically normal (CN) acute myeloid leukemia (AML): A Cancer and
Leukemia Group B (CALGB) study. |
| |
|
| Time: |
12:00 PM |
| Rooms: |
Rooms A411-A412 |
| Presenters: |
Jeffrey E. Lancet, Jason Gotlib, Meir Wetzler, Selina Luger, Larry D.
Cripe, Martin S. Tallman, Ivana Gojo, Deborah Mulford,
Maria R. Baer, Alan F. List, Pratik S. Multani, Branimir
I. Sikic. Phase I/II study of the P-glycoprotein inhibitor zosuquidar
administered by continuous infusion with daunorubicin and cytarabine as
primary therapy in older patients with Pgp-positive acute myeloid leukemia. |
top
Poster Presentations
Saturday, December 8, 2007
|
Poster 599-I
|
| Room: |
Hall B4 |
| Presenters: |
Mitch Raponi, Jeffrey E. Lancet, Hongtao Fan, Lesley Dossey, Grace
Lee, Ivana Gojo, Eric J. Feldman, Jason Gotlib, Lawrence
Harousseau, Bob Lowenberg, Richard M. Stone, Peter De Porre, Yixin Wang,
Judith E. Karp. A two-gene classifier for predicting response to the
farnesyltransferase inhibitor tipifarnib in
acute myeloid leukemia. |
| |
|
Poster 604-I
|
| Presenters: |
David P Steensma, Maria R. Baer, James L Slack, Rena
Buckstein, Lucy Godley, Julie S Larsen, Michael T Cullen, Hagop M Kantarjian.
Preliminary results of a phase II study of decitabine administered daily
for 5 days every 4 weeks to adults with myelodysplastic syndrome (MDS).
|
| |
|
Poster 624-I
|
| Presenters: |
Alan F List, Maria R. Baer, David P Steensma, Azra
Raza, J Esposito J, J Virkus, J Feigert, E Besa E, C Paley. Deferasirox
(ICL670; Exjade®) reduces serum ferritin (SF) and labile plasma iron
(LPI) in patients with myelodysplastic syndromes (MDS). |
top
University of Maryland
Session Chairs
Maria R. Baer
Sunday, December 9, 2007, 4:30-6:00 PM
Room A305
Disordered Gene Expression in Leukemia
Maria R. Baer
Monday, December 10, 2007, 11 AM-12:30 PM
Rooms A411-A412
Acute Myeloid Leukemias: Therapy, excluding Transplantation-Results of Clinical
Trials
Ronald B. Gartenhaus
Monday. December 10, 2007, 11 AM-12:30 PM
Room A305
Disordered Gene Expression in Hematologic Malignancy, including Disordered
Epigenetic Regulation
top
This page was last updated on: December 12, 2007.
Email this Page
Print this Page
